20 ML dexmedetomidine 0.004 MG/ML Injection — RxCUI 1718900
RxNorm drug concept · Semantic clinical drug
RxCUI 1718900
Semantic clinical drug · SCD
● Current RxNorm concept 19 FDA products
23 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1718900
Official name20 ML dexmedetomidine 0.004 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdexmedetomidine (as dexmedetomidine HCl) 80 MCG per 20 ML Injection; dexmedeTOMIDine HCl 80 MCG in 20 ML Injection
FDA products mapped19
Package NDCs mapped23
Reported Medicaid activity (SDUD)8,519 prescriptions · 16 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dexmedetomidine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Dexmedetomidine is a sedative used in hospital settings. If you're receiving the IV form, it's being used to keep you calm and comfortable — either while you're on a breathing mach...
- Why am I getting dexmedetomidine — what is it actually used for?
- Dexmedetomidine causes sedation, but it's different from general anesthesia. Some patients can actually be roused — meaning if someone calls your name or stimulates you, you may op...
- Will I be completely unconscious, or will I be able to wake up?
🕸️ Concept Web — How 20 ML dexmedetomidine 0.004 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
20 ML dexmedetomidine 0.004 MG/ML Injection
RxCUI 1718900 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Dexmedetomidine
48937IN
-
Dexmedetomidine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Precedex
262138BN
-
Precedex
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dexmedetomidine Injection
1718899SCDF -
Dexmedetomidine Injectable Product
1154546SCDG -
Dexmedetomidine Injection [Precedex]
1718901SBDF -
Precedex Injectable Product
1185233SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Dexmedetomidine Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dexmedetomidine 0.004 MG/ML
1249680SCDC -
20 ML dexmedetomidine 0.004 MG/ML Injection [Precedex]
1718902SBD -
Dexmedetomidine 0.004 MG/ML [Precedex]
1373736SBDC
-
Dexmedetomidine 0.004 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dexmedetomidine 0.004 MG/ML
SCDC · 1249680 -
Dexmedetomidine Injection
SCDF · 1718899 -
Dexmedetomidine Injectable Product
SCDG · 1154546
Brand-Name Concepts
-
20 ML dexmedetomidine 0.004 MG/ML Injection [Precedex]
SBD · 1718902 -
Dexmedetomidine 0.004 MG/ML [Precedex]
SBDC · 1373736 -
Dexmedetomidine Injection [Precedex]
SBDF · 1718901 -
Precedex Injectable Product
SBDG · 1185233 -
Precedex
BN · 262138
📦 FDA Products & Package NDCs
19 products · 23 package NDCs
23 package NDCs map to RxCUI 1718900 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00409-1174-10 | 10 BOTTLE in 1 TRAY (0409-1174-10) / 100 mL in 1 BOTTLE (04... | Precedex | Hospira, Inc. | 2022-03-07 |
| 00409-1434-01 | 1 BOTTLE in 1 CARTON (0409-1434-01) / 250 mL in 1 BOTTLE | Precedex | Hospira, Inc. | 2020-09-28 |
| 00409-1454-20 | 20 BOTTLE in 1 TRAY (0409-1454-20) / 50 mL in 1 BOTTLE (040... | Precedex | Hospira, Inc. | 2022-03-07 |
| 00409-1596-10 | 10 CARTON in 1 CASE (0409-1596-10) / 1 BOTTLE in 1 CARTON (... | Precedex | Hospira, Inc. | 2023-11-13 |
| 00409-1638-02 | 25 VIAL in 1 TRAY (0409-1638-02) / 2 mL in 1 VIAL (0409-163... | Precedex | Hospira, Inc. | 2004-11-30 |
| 00409-1660-10 | 10 BOTTLE in 1 TRAY (0409-1660-10) / 100 mL in 1 BOTTLE (04... | Precedex | Hospira, Inc. | 2013-04-08 |
| 00409-1660-20 | 10 VIAL in 1 CARTON (0409-1660-20) / 20 mL in 1 VIAL (0409-... | Precedex | Hospira, Inc. | 2015-01-05 |
| 00409-1660-50 | 20 BOTTLE in 1 TRAY (0409-1660-50) / 50 mL in 1 BOTTLE (040... | Precedex | Hospira, Inc. | 2013-04-08 |
| 00409-2815-01 | 1 BOTTLE in 1 CARTON (0409-2815-01) / 250 mL in 1 BOTTLE | Precedex | Hospira, Inc. | 2023-01-17 |
| 00409-3301-10 | 10 VIAL in 1 CARTON (0409-3301-10) / 20 mL in 1 VIAL (0409-... | Precedex | Hospira, Inc. | 2022-03-07 |
| 00409-7838-24 | 24 POUCH in 1 CASE (0409-7838-24) / 1 BAG in 1 POUCH / 50 m... | Precedex | Hospira, Inc. | 2025-03-24 |
| 00409-7853-24 | 24 POUCH in 1 CASE (0409-7853-24) / 1 BAG in 1 POUCH / 100... | Precedex | Hospira, Inc. | 2025-03-24 |
| 00409-7875-12 | 12 POUCH in 1 CASE (0409-7875-12) / 1 BAG in 1 POUCH / 250... | Precedex | Hospira, Inc. | 2025-03-24 |
| 00781-3493-95 | 10 VIAL in 1 CARTON (0781-3493-95) / 20 mL in 1 VIAL | DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | Sandoz Inc. | 2020-06-12 |
| 00781-3494-95 | 10 BOTTLE in 1 CARTON (0781-3494-95) / 50 mL in 1 BOTTLE | DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | Sandoz Inc. | 2020-06-12 |
| 00781-3495-95 | 10 BOTTLE in 1 CARTON (0781-3495-95) / 100 mL in 1 BOTTLE | DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | Sandoz Inc. | 2020-06-12 |
| 68094-0047-10 | 10 VIAL in 1 CARTON (68094-047-10) / 20 mL in 1 VIAL (68094... | Dexmedetomidine Hydrochloride in Sodium Chloride | Precision Dose, Inc. | 2020-11-23 |
| 68094-0147-20 | 20 BOTTLE in 1 CARTON (68094-147-20) / 50 mL in 1 BOTTLE (6... | Dexmedetomidine Hydrochloride in Sodium Chloride | Precision Dose, Inc. | 2020-11-23 |
| 68094-0247-10 | 10 BOTTLE in 1 CARTON (68094-247-10) / 100 mL in 1 BOTTLE (... | Dexmedetomidine Hydrochloride in Sodium Chloride | Precision Dose, Inc. | 2020-11-23 |
| 71225-0126-04 | 10 VIAL in 1 CARTON (71225-126-04) / 20 mL in 1 VIAL (71225... | DEXMEDETOMIDINE HYDROCHLORIDE | Slayback Pharma LLC | 2021-12-11 |
| 71225-0126-05 | 20 BOTTLE in 1 CARTON (71225-126-05) / 50 mL in 1 BOTTLE (7... | DEXMEDETOMIDINE HYDROCHLORIDE | Slayback Pharma LLC | 2019-12-06 |
| 71225-0126-06 | 10 BOTTLE in 1 CARTON (71225-126-06) / 100 mL in 1 BOTTLE (... | DEXMEDETOMIDINE HYDROCHLORIDE | Slayback Pharma LLC | 2019-12-06 |
| 84549-0493-95 | 20 mL in 1 VIAL (84549-493-95) | DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | ProPharma Distribution | 2025-10-10 |
Observed labelers:
Hospira, Inc. (13) ·
Precision Dose, Inc. (3) ·
Sandoz Inc. (3) ·
Slayback Pharma LLC (3) ·
ProPharma Distribution (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.